Evidence for direct and indirect mechanisms in the potent modulatory action of interleukin-2 on the release of acetylcholine in rat hippocampal slices

British Journal of Pharmacology

Volumn 120, Issue 6, 1997, Pages 1151-1157

  Seto, David ^a   Kar, Satyabrata ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

aminobutyric acid (GABA); Acetylcholine; Cytokine; Hippocampus; Interleukin 2; Release

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ANTIBODY; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CHOLINERGIC NERVE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; BACLOFEN; BICUCULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA ANTAGONISTS; HIPPOCAMPUS; INTERLEUKIN-2; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-2; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN;

EID: 0030903530     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701002     Document Type: Article

References (66)

1. 3H]dopamine in rat cultured mesencephalic cells. J. Neurochem., 61, 1284-1290.
2. ARAUJO, D.M. & LAPCHAK, P.A. (1994). Induction of immune system mediators in the hippocampal formation in Alzheimer's and Parkinson's disease: selective effects on specific interleukins and interleukin receptors. Neuroscience, 61, 745-754.
3. ARAUJO, D.M., LAPCHAK, P.A., COLLIER, B. & QUIRION, R. (1989). Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res., 498, 257-266.
4. ARAUJO, D.M., LAPCHAK, P.A., COLLIER, B. & QUIRION, R. (1990). Interleukin-2 interacts with opioid neuroregulatory systems in the rat hippocampus. Prog. Clin. Biol. Res., 328, 355-358.
5. B antagonists prevent the opioid inhibition of endogenous acetylcholine release evoked by glutamate from rat neostriatal slices. Neurosci. Lett., 120, 201-204.
6. AWATSUJI, H., FURUKAWA, Y., NAKAJIMA, M., FURUKAWA, S. & HAYASHI, K. (1993). Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain. J. Neurosci. Res., 35, 305-311.
7. BAMFORD, R.N., GRANT, A.J., BURTON, J.D., PETERS, C., KURYS, G., GOLDMAN, C.K., BRENNAN, J., ROESSLER, E. & WALDMANN, T.A. (1994). The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T. that stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc. Nat. Acad. Sci. U.S.A., 91, 4940-4944.
8. BARTUS. R.T., DEAN, R.L. III, BEER, B. & LIPPA, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-414.
9. BENVENISTE, E.N. & MERRILL, J.E. (1986). Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature, 321, 610-613.
10. BIANCHI, M. & PANERAI, A.E. (1993). Interleukin-2 enhances scopolamine-induced amnesia and hyperactivity in the mouse. Neuro Report, 4, 1046-1048.
11. BJORKLUND, A. & DUNNETT, S.B. (1995). Acetylcholine revisited. Nature, 375, 446.
12. BREDT. D.S., GLATT, C.E., HWANG, P.M., FOTUHI, M., DAWSON, T.M. & SYNDER, S.H. (1991). Nitric oxide protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron, 7, 615-624.
13. CAMBRONERO, J., RIVAS, F.J., BORRELL, J. & GUAZA, C. (1992). Interleukin-2 induces corticotrophin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids. Endocrinology, 131, 677-683.
14. DEPPER, J.M., LEONARD, W.J., ROBB, R.J., WALDMANN, T.A. & GREENE, W.C. (1983). Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J. Immunol., 131, 690-696.
15. DE SARRO, G.B., MASUDA, Y., ASCIOTI, C., AUDINO, M.G. & NISTICÒ, G. (1990). Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin-2 are antagonized by naloxone. Neuropharmacology, 29, 167-179.
16. EITAN, S. & SCHWARTZ, M. (1993). A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocyles. Science, 261, 106-108.
17. EITAN, S., ZISLING, R., COHEN, A., BELKIN, M., HIRSCHBERG, D.L., LOTAN, M. & SCHWARTZ, M. (1992). Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration. Proc Natl. Acad. Sci. U.S.A., 89, 5442-5446.
18. EIZENBERG, O., FABERR-ELMAN, A., LOTAN, M. & SCHWARTZ, M. (1995). Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem., 64, 1928-1936.
19. FINKEL, M.S., ODDIS, C.V., JACOB, T.D., WATKINS, S.C., HATTLER, B.G. & SIMMONS, R.L. (1992). Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257, 387-389.
20. FONNUM, F. (1969). Isolation of choline esters from aqueous solutions by extraction with sodium tetraphenylboron in organic solvents. Biochem. J., 113, 291-298.
21. GIRI, J.G., AHDIEH, M., EISENMAN, J., SHANEBECK, K., GRABSTEIN, K., KUMAKI, S., NAMEN, A., PARK, L.S., COSMAN, D. & ANDERSON, D. (1994). Utilization of the β and γ chains of IL-2 receptor by the novel cytokine IL-15. EMBO J., 13, 2822-2830.
22. GOLDBERG, A.M. & MCCAMAN, R.E. (1973). The determination of picomole amounts of acetylcholine in mammalian brain. J. Neurochem., 20, 1-8.
23. GRABSTEIN, K.H., EISENMAN, J., SHANEBECK, K., RAUCH, C., SRINIVASAN, S., FUNG, V., BEERS, C., RICHARDSON, J., SCHOENBORN, M.A., AHDIEH, M., JOHNSON, L., ALDERSON, M.R., WATSON, J.D., ANDERSON, D.M. & GIRI, J.G. (1994). Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science, 264, 965-968.
24. HANISCH, U.K., SETO, D. & QUIRION, R. (1993). Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J. Neurosci., 13, 3368-3374.
25. HAUGEN, P.K. & LETOURNEAU, P.C. (1990). Interleukin-2 enhances chick and rat sympathetic, but not sensory, neurite outgrowth. J. Neurosci. Res., 25, 443-452.
26. HILLHOUSE, E.W. (1994). Interleukin-2 stimulates the secretion of arginine vasopressin but not corticotropin-releasing hormone from rat hypothalamic cells in vitro. Brain Res., 650, 323-325.
27. JIANG, C.L., LU, C.L. & LIU, X.Y. (1995). Multiple actions of cytokines in the CNS. Trends Neurosci., 18, 296.
28. KARANTH, S., LYSON, K. & MCCANN, S.M. (1993). Role of nitric oxide in interleukin-2-induced corticotropin-releasing factor release from incubated hypothalami. Proc. Natl. Acad. Sci. U.S.A., 90, 3383-3387.
29. KARANTH, S. & MCCANN, S.M. (1991). Anterior pituitary hormone control by interleukin 2. Proc. Natl. Acad. Sci. U.S.A., 88, 2961-2965.
30. KISHIMOTO, T., TETSUYA, T. & AKIRA, S. (1994). Cytokine signal transduction. Cell, 76, 253-262.
31. LAPCHAK, P.A. (1992). A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuro Report, 3, 165-168.
32. LAPCHAK, P.A. & ARAUJO, D.M. (1993). Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus. Neuro Report, 4, 303-306.
33. LAPCHAK, P.A., ARAUJO, D.M. & COLLIER, B. (1989). Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea pig and rat. Neuroscience, 31, 313-325.
34. LAPCHAK, P.A., ARAUJO, D.M., QUIRION, R. & BEAUDET, A. (1990). Neurotensin regulation of endogenous acetylcholine release from rat cerebral cortex: effect of quinolinic acid lesions of the basal forebrain. J. Neurochem., 55, 1397-1403.
35. LAPCHAK, P.A., ARAUJO, D.M., QUIRION, R. & BEAUDET, A. (1991). Immunoautoradiographic localization of interleukin-2-like immunoreactivity and interleukin-2 receptors (Tac antigen-like immunoreactivity) in the rat brain. Neuroscience, 44, 173-184.
36. LONART, G., WANG, J. & JOHNSON, K.M. (1992). Nitric oxide induces neurotransmitter release from hippocampal slices. Eur. J. Pharmacol., 220, 271-272.
37. LOWRY. O.H., ROSEBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurements with the Folin phenol reagent. J. Biol. Chem., 193, 165-175.
38. LUBER-NAROD, J. & ROGERS, J. (1988). Immune system associated antigens expressed by cells of the human central nervous system. Neurosci. Lett., 94, 17-22.
39. MCCORMICK, D.A. (1989). GABA as an inhibitory neurotransmitter in human cerebral cortex. J. Neurophysiol., 62, 1018-1027.
40. MCGEER, P.L., ROGERS, J. & MCGEER, E.G. (1994). Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis. Assoc. Disord., 8, 149-158.
41. MENNICKEN, F. & QUIRION, R. (1996). Interleukin-2 increases choline acetyltransferase activity in septal cell cultures. Synapse, (in press).
42. MERRILL, J.E. (1990) lnterleukin-2 effects in the central nervous system, Ann. New York Acad. Sci., 594, 188-199.
43. NIETO-SAMPEDRO, M. & CHANDY, K.G. (1987). Interleukin-2-like activity in injured rat brain. Neurochem. Res., 12, 723-727.
44. NISTICÒ, G. & DE SARRO, G.B. (1991). Is interleukin-2 a neuromodulator in the brain? Trends Neurosci., 14, 146-150.
45. B receptors in locus coeruleus: effects of blockers. Eur. J. Pharmacol., 149, 183-185.
46. PETITTO, J.M. & HUANG, Z. (1994). Molecular cloning of a partial cDNA of the interleukin-2 receptor in normal mouse brain: in situ localization in the hippocampus and expression by neuroblasloma cells. Brain Res., 650, 140-145.
47. PETITTO, J.M. & HUANG, Z. (1995). Molecular cloning of the coding sequence of an interleukin-2 receptor a subunit cDNA in murine brain. J. Neuroimmunol., 59, 135-141.
48. PLATA-SALAMÁN, C.R. (1991). Immunoregulators in the nervous system. Neurosci. Biobehav. Rev., 15, 185-215.
49. PLATA-SALAMÁN, C.R. & FFRENCH-MULLEN, J.M.H. (1993). Interleukin-2 modulates calcium currents in dissociated CAI hippocampal neurons. Neuro Report, 4, 579-581.
50. RABER, J. & BLOOM, F.E. (1994). Interleukin-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediating signaling. J. Neurosci., 14, 6187-6195.
51. RABER, J., KOOB, G.F. & BLOOM, F.E. (1995). Interleukin-2 (IL-2) induces corticotropin-releasing factor release from the amygdala and involves a nitric oxide-mediated signalling: comparision with the hypothalamic response. J. Pharmacol. Exp. Ther., 272, 815-824.
52. SARDER, M., SAITO, H. & ABE, K. (1993). Interleukin-2 promotes survival and neunte extension of cultured neurons from fetal rat brain. Brain Res., 625, 347-350.
53. SAWADA, M., SUZUMARA, A. & MARUNOUCHI, T. (1995). Induction of functional interleukin-2 receptor in mouse microglia. J. Neurochem., 64, 1973-1979.
54. SELKOE, D.J. (1993). Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci., 16, 403-409.
55. SETO, D., HANISCH, U.K., CHABOT, J.G. & QUIRION, R. (1991). Evoked efflux of endogenous acetylcholine from rat brain slices: effect of IL-2. Soc. Neurosci. Abstr., 17, 782.
56. SETO, D., HANISCH, U., VILLEMAIN, F., BEAUDET, A. & QUIRION, R. (1993). Anatomical and functional approaches to the study of interleukin-2 and its receptors in the brain. In Neurobiology of Cytokines, Part A. ed. de Souza, E.B., Methods in Neurosci., Vol. 16, pp. 173-184. San Diego: Academic Press.
57. SHIMOJO, M., IMAI, Y., NAKAJIMA, K., MIZUSHIMA, S., UEMURA, A. & KOHSAKA, S. (1993). Interleukin-2 enhances the viability of primary cultured rat neocortical neurons. Neurosci. Lett., 151, 170-173.
58. SIVILOTTI, L. & NISTRI, A. (1991). GABA receptor mechanisms in the central nervous system. Prog. Neurobiol., 36, 35-92.
59. +-dependent IPSP in cat and rat thalamic and hippocampal neurons. Brain Res., 448, 351-354.
60. TANCREDI, V., ZONA, C., VELOTTI, F., EUSEBI, F. & SANTONI, A. (1990). Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res., 525, 149-151.
61. TANIGUCHI, T. & MINAMI, Y. (1993). The IL-2/IL-2 receptor system: a current overview. Cell, 73, 5-8.
62. THOMPSON, S.M. (1994). Modulation of inhibitory synaptic transmission in the hippocampus. Prog Neurobiol., 42, 575-609.
63. VILLEMAIN, F., GIRARD, J.M., OWENS, T. & BEAUDET, A. (1990). Immunohistochemical detection of interleukin-2 in normal mouse brain. Soc. Neurosci Abstr., 16, 1213.
64. VILLEMAIN, F., OWENS, T., RENNO, T. & BEAUDET, A. (1991). Localization of mRNA for IL-2 in mouse brain by in situ hybridization. Soc. Neurosci. Abstr., 17, 1199.
65. VILLEMAIN, F., SETO, D., QUIRION, R. & BEAUDET, A. (1992). Modulation of catecholamine release by interleukin-2 (IL-2) in mouse hypothalamus. Soc. Neurosci. Abstr., 18, 482.
66. WOOD, M.J.A., SLOAN, D.L., DALLMAN, M.J. & CHARLTON, H.M. (1992). A monoclonal antibody to the interleukin-2 receptor enhances the survival of neural allografts: a time-course study. Neuroscience, 49, 409-418.